News
SGX301 has shown rapid and sustained benefit in early cutaneous T-cell lymphoma in an investigator-initiated study, with good ...
4d
Stockhead on MSNTop 10 at 11: ASX unsure which way to jump as tariff talk dampens US marketsIt's a subdued start to trading with tariff talk dampening US markets. Pharmaceutical and Energy stocks are the unlucky ...
The company is targeting Cutaneous T Cell Lymphoma and more specifically mycosis fungoides, a rare type of skin lymphoma. Finally, Norwest Minerals (ASX:NWM) has obtained a mining lease covering ...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
The clinical study RW-HPN-MF-01, "Assessment of Treatment with Visible Light Activated Synthetic Hypericin Ointment in Mycosis Fungoides ... About Cutaneous T-Cell Lymphoma (CTCL) CTCL is a ...
A new study has revealed that a special group of cells in the intestines tamp down the immune responses caused by exposure to food proteins. Called 'tolerogenic dendritic cells,' these cells enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results